Lorsqu'un laboratoire souhaite commercialiser une nouvelle molécule, il dépose un brevet, et la commercialisation du médicament, dit « princeps », reste protégée généralement de 10 à 15 ans.... Lire la suite
When a pharmaceutical company wants to market a new molecule, it applies for a patent. The patented drug, known as the "originator" drug, is generally protected for between 10 and 15 years. After the patent expires, the pharmaceutical company no longer has the monopoly on manufacturing the drug, and can face competition from generic pharmaceutical firms. In France, whether they are made by generic... Lire la suite